The Art and Practice of UVB Phototherapy for the Treatment of Psoriasis

Therapy of Moderate-to-Severe Psoriasis, Second Edition, Revised and Expanded

Volumn , Issue , 2003, Pages 53-90

  Koo, John ^a   Bandow, Grace ^a   Feldman, Steven R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33645442412     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b14220-7     Document Type: Chapter

References (90)

1. Koo J, Lebwohl M. Duration of remission of psoriasis therapies. J Am Acad Dermatol 1999; 41(1):51–59.
2. Birt AR, Davis RA. Hereditary polymorphic light eruption of American Indians. Int J Dermatol. 1975; 14:105–111.
3. Gshnait G, Honigsmann H, Brenner W, et al. Induction of UV light tolerance by PUVA in patients with polymorphous light eruption. Br J Dermatol. 1978;99:293–295.
4. Elmets CA. Drug induced photoallergy. In: DeLeo VA, ed. Photosensitivity Diseases Dermatol Clin. 1986; 4(2):231–241.
5. Valerie K, Delers A, Bruck C, et al. Activation of human immunodeficiency virus type 1 by DNA damage in human cells. Nature. 1988;333:78–81.
6. Stein B, Kramer M, Rahmsdorf HJ, Ponta H, Herrlich P. UV-induced transcription from the human immunodeficiency virus type 1 (HIV-1) transcription in nonirradiated cells. J Virol. 1989;63:4540–4544.
7. Legrand-Poels S, Vaira D, Pincemil J, Van de Vorst A, Piette J. Activation of human immunodeficiency virus type1 by oxidative stress. AIDS Res Hum Retroviruses. 1990;6:1389–1397.
8. Osborn L, Kunkel S, Nabel GJ. Tumor necrosis and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kB. Proc Natl Acad Sci USA. 1989; 86:2336–2340.
9. Meola T, Soter NA, Ostreicher R, et al. The safety of UVB phototherapy in patients with HIV infection. J Am Acad Dermatol. 1993;29:216–220.
10. Adrian RM, LeVine MJ, Parrish JA. Treatment frequency for outpatient phototherapy of psoriasis. A comparative study. Arch Dermatol. 1981;117: 623–626.
11. LeVine MJ, Parrish JA. Outpatient phototherapy of psoriasis. Arch Dermatol. 1980;116:552–554.
12. Menkes A, Stern RS, Arndt KA. Psoriasis treatment with suberythemogenic ultraviolet B radiation and a coal tar extract. J Am Acad Dermatol. 1984;12:21–25.
13. Morison WL. Phototherapy and Photochemotherapy of Skin Disease, 2nd ed. New York: Raven Press, 1991:80.
14. Petrozzi JW. Updating the Goeckerman regimen for psoriasis. Br J Dermatol. 1987;98:437–444.
15. Stern RS. Effect of continued ultraviolet B phototherapy on the duration of remission of psoriasis: a randomized study. J Am Acad Dermatol. 1986; 15:546–552.
16. Lowe NJ, Wortzman MS, Breeding J, et al. Coal tar phototherapy for psoriasis reevaluated: erythematous versus suberythemogenic ultraviolet with a tar extract in oil and crude coal tar. J Am Acad Dermatol. 1983;8:781–789.
17. Belsito DV, Kechijian P. The role of tar in Goeckerman therapy. Arch Dermatol. 1982;118:319–321.
18. Petrozzi JW, De los Reyes O. Ultraviolet phototherapy in psoriasis with hydrophilic ointment alone or with crude coal tar. Arch Dermatol Res. 1982;272:257–262.
19. LeVine M, White HAD, Parrish JA. Components of the Goeckerman therapy. J Invest Dermatol. 1979;73:170–173.
20. Frost P. Tar gel-phototherapy for psoriasis. Arch Dermatol. 1979;115:840–846.
21. Pittelkow MR, Perry HO, Muller SA, et al. Skin cancer in patients with psoriasis treated with coal tar. Arch Dermatol. 1981;117:465–468.
22. Alderson MR, Clarke JA. Cancer incidence in patients with psoriasis. Br J Cancer. 1983;47:857–859.
23. Larko O, Swanbeck kG. Is UVB treatment in psoriasis safe? A study of exclusively UVB-treated psoriasis patients compared with a matched control group. Acta Derm Venereol (Stockh). 1982;62:507–512.
24. Olson RL, Sayre RM, Everett MA. Effect of anatomic location and time on ultraviolet erythema. Arch Dermatol. 1996;93:211–215.
25. Chue B, Borok M, Lowe NJ. Phototherapy units; comparison of fluorescent ultraviolet B and ultraviolet A units with a high-pressure mercury system. J Am Acad Dermatol. 1988;18:641–645.
26. Kokelj S, Lavaroni G, Guadagnini A. UVB versus UVB plus calcipotriol therapy for psoraisis vulgaris. Acta Derm Venereol (Stockh). 1995;75:386–387.
27. Ramsay CA, Schwartz BE, Lowson D, et al. Calcipotriol cream combined with twice weekly broad-band UVB phototherapy: a safe, effective and UVBsparing antipsoriatric combination treatment. The Canadian Calcipotriol and UVB Study Group. Dermatology. 2000;200(1):17–24.
28. Koo J, Lowe N, Lew-Kaya D, Vasilopoulos A, Lue J, Sefton J, Gibson J. Tazarotene Plus UVB phototherapy in the treatment of psoriasis. J Am Acad Dermatol. 2000 Nov; 43(5 Pt 1):821–828.
29. Paul BS, Momtaz K, Stern RS, et al. Combined methotrexate–ultraviolet B therapy in treatment of psoriasis. J Am Acad Dermatol. 1982;7:758–762.
30. Oxholm A, Thomsen K, Menne T. Squamous cell carcinomas in relation to cyclosporin therapy of non-malignant skin disorders. Acta Derm Venereol (Stockh). 1989;69:89–90.
31. Krupp P, Monka C. Side-effect profile of cyclosporin A in patients treated for psoriasis. Br J Dermatol. 1990;122(suppl 36):47–56.
32. Penn I. Cancers following cyclosporin therapy. Transplantation. 1987;43:32–35.
33. Parrish JA, Jaenicke KF. Action spectrum for phototherapy of psoriasis. J Invest Dermatol 1981; 76:359–362.
34. Diffey BL, Farr PM. An appraisal of ultraviolet lamps used for the phototherapy of psoriasis. Br J Dermatol 1987; 117:49–56.
35. Van Weelden H, Young E, van der Leun JC. Therapy of psoriasis: comparison of photochemotherapy and several variants of phototherapy. Br J Dermatol 1980; 103:I.
36. Van Weelden H, van der Leun JC. Improving the effectiveness of phototherapy for psoriasis. Br J Dermatol 1984; 111:484.
37. Van Weelden H, Baart de la Faille H, Young E, van der Leun JC. A new development inUVBphototherapy of psoriasis. Br J Dermatol. 1988; 119:11–19.
38. Coven TR, Burack LH, Gilleaudeau P, Keogh M, Ozawa M, Krueger JG. Narrow band UV-B produces superior clinical and histolpathological resolution of moderate-to-severe psoriasis in patients compared with broadband UV-B. Arch Dermatol 1997; 133:1514–1522.
39. Karvonen J, Kokkonen EL, Ruotsalainen E. 311 nm UVB lamps in the treatment of psoriasis with the Ingram regimen. Acta Derm Venereol (Stockh) 1989; 69:82–85.
40. Picot E, Meunier L, Picot-Debeze MC. Treatment of psoriasis with a 311-nm UVB lamp. Br J Dermatol 1992; 127:509–512.
41. Green C, Ferguson J, Lakshmipathi T, Johnson BE. 311 nm UVB phototherapy— an effective treatment for psoriasis. Br J Dermatol 1988; 119:691–696.
42. Larko O. Treatment of psoriasis with a new UVB-lamp. Acta Derm Veneorol (Stockh) 1989; 69:357–359.
43. Fischer T, Alsins J, Berne B. Ultraviolet action spectrum and evaluation of ultraviolet lamps for psoriasis healing. Int J Dermatol 1984; 23:633–637.
44. Hofer A, Fink-Puches R, Kerl H, Wolf P. Comparison of phototherapy with near vs. far erythremogenic doses of narrow-band ultraviolet B in patients with psoriasis. Br J Dermatol 1998; 138:96–100.
45. Walters IB, Burack LH, Coven TR, Gilleaudeau P, Krueger JG. Suberythemogenic narrow-band UVB is markedly more effective than conventional UVB in treatment of psoriasis vulgaris. J Am Acad Dermatol 1999; 40:893–900.
46. Behrens S, Grundmann-Kollmann M, Schiener R, Peter RU, Kerscher M. Combination phototherapy of psoriasis with narrow-band UVB irradiation and topical tazarotene gel. J Am Acad Dermatol. 2000;42:493–495.
47. Carrozza P, Hausermann P, Nestle FO, Burg G, Boni R. Clinical efficacy of narrow-band UVB (311nm) combined with dithranol in psoriasis. Dermatology 2000; 200:35–39.
48. Kerscher M, Volkenandt M, Plewig G, Lehmann P. Combination phototherapy of psoriasis with calcipotriol and narrow-band UVB [letter]. Lancet 1993; 342:923.
49. Green C, Ferguson J, Lakshmipathi T, Johnson BE. 311 nm UVB phototherapy— an effective treatment for psoriasis. Br J Dermatol 1988; 119:691–696.
50. Van Weelden H, Baart De La Faille H, Young E, Van Der Leun JC. Comparison of narrow-band UV-B phototherapy and PUVA photochemotherapy in the treatment of psoriasis. Acta Derm Venereol (Stockh) 1990; 70:212–215.
51. Tanew A, Radakovic-Fijan S, Schemper M, Honigsmann H. Narrow-band UV-B phototherapy vs photochemotherapy in the treatment of chronic plaque-type psoriasis: A paired comparison study. Arch Dermatol. 1999; 135:519–524.
52. Hofer A, Fink-Puches R, Kerl H, Wolf P. Comparison of phototherapy with near vs. far erythremogenic doses of narrow-band ultraviolet B in patients with psoriasis. Br J Dermatol 1998; 138:96–100.
53. Gordon PM, Diffey BL, Matthews JNS, Farr PM. A randomized comparison of narrow-band TL-01 phototherapy and PUVA photochemotherapy for psoriasis. J Am Acad Dermatol 1999; 41(5 Pt1):728–732.
54. George SA, Bilsland DJ, Johnson BE, Ferguson J. Narrow-band (TL-01) UVB air-conditioned phototherapy for chronic sever adult atopic dermatitis. Br J Dermatol 1993; 128:49–56.
55. Grundmann-Kollmann M, Behrens S, Podda M, Peter RU, Kaufmann R, Kerscher M. Phototherapy for atopic eczema with narrow-band UVB. J Am Acad Dermatol 1999; 40:995–997.
56. Hudson-Peacock MJ, Diffey BL, Farr PM. Narrow-band UVB phototherapy for severe atopic dermatitis. Br J Dermatol 1996; 135:332.
57. Reynolds NJ, Franklin V, Gray JC, Diffey BL, Farr PM. Narrow-band ultraviolet B and broad-band ultraviolet A phototherapy in adult atopic eczema: a randomized controlled trial. Lancet 2001; 357:2012–2016.
58. Pikhammer D, Seeber A, Honigsmann H, Tanew A. Narrow-band ultraviolet B (TL-01) phototherapy is an effective and safe treatment option for patients with severe seborrhoeic dermatitis. Br J Dermatol 2000; 143:964–968.
59. Bilsland D, George SA, Gibbs NK, Aitchison T, Johnson BE, Ferguson J. A comparison of narrow band phototherapy (TL 01) and photochemotherapy (PUVA) in the management of polymorphic light eruption. Br J Dermatol 1993; 129:708–712.
60. Collins P, Ferguson J. Narrow-band UVB (TL-01) phototherapy: an effective preventative treatment for the photodermatoses. Br J Dermatol 1995; 132:956–963.
61. Gupta G, Man I, Kemmett D. Hydroa vacciniforme: a clinical and follow-up study of 17 cases. J Am Acad Dermatol 2000; 42:208–213.
62. Westerhof W, Nieuweboer-Krobotova L. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A. Arch Dermatol 1997; 133:1525–1528.
63. Scherschun L, Kim JJ, Lim HW. Narrow-band ultraviolet B is a useful and welltolerated treatment for vitiligo. J Am Acad Dermatol 2001; 44(6):999–1003.
64. Njoo MD, Bos JD, Westerhof W. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol 2000; 42:245–253.
65. Alora MBT, Taylor CR. Narrow-band (311) UVB phototherapy: an audit of the first year’s experience at the Massachusetts General Hospital. Photodermatol Photoimmunol Photomed 1997; 13:82–84.
66. Wulf HC, Hansen AB, Bech-Thomsen N. Differences in narrow-band ultraviolet B and broad-spectrum ultraviolet photocarcinogenesis in lightly pigmented hairless mice. Photodermatol Photoimmunol Photomed 1994; 10:192–197.
67. George SA, Ferguson J. Lesional blistering following narrow-band (TL-01) UVB phototherapy for psoriasis: a report of four cases. Br J Dermatol 1992; 127:445–446.
68. Calzavara-Pinton PG, Zane C, Candiago E, Facchetti F. Blisters on psoriatic lesions treated with TL-01 lamps. Dermatol 2000; 200:115–119.
69. Stern RS, Laird N. The carcinogenic risk of treatments for severe psoriasis. Cancer 1994; 73(11):2759–2764.
70. Koo JYM, Fitzpatrick TB, Krueger G, Lebwohl M, Menter A, Taylor JR. PUVA phototherapy: assessing and optimizing the risk/benefit ratio. Skin Allergy News Suppl 2001; 32(2):1–15.
71. Freeman RG. Data on the action spectrum for ultraviolet carcinogenesis. J Natl Caner Inst 1975; 55:1119–1122.
72. Flindt-Hansen H, McFadden N, Eeg-Larsen T, Thune P. Effect of a new narrow-band UV-B lamp on photocarcinogenesis in mice. Acta Derm Venereol (Stockh) 1991; 71:245–248.
73. Shelk J, Morgan P. Narrow-Band UVB: A practical approach. Dermatol Nurs 2000;12(6):407–411.
74. Zanolli MD, Clark AR, Feldman SR, Fleischer AB, Jr. Phototherapy treatment protocols: for psoriasis and other phototherapy responsive dermatoses. New York: CRC Press-Parthenon Publishing, 2000.
75. Pasker-de Jong PC, Wielink G, van der Valk G, van der Wilt GJ. Treatment with UV-B for psoriasis and nonmelanoma skin cancer: a systematic review of the literature. Arch Dermatol 1999;135:834–840.
76. Al Suwaidan SN, Feldman SR. Clearance is not a realistic expectation of psoriasis treatment. J Am Acad Dermatol 2000; 42:796–802.
77. Rapp SR, Exum ML, Reboussin DM, Feldman SR, Fleischer AB, Clark AR. The physical, psychological and social impact of psoriasis. J Health Psychol 1997;2:525–537.
78. Avrillier S, Ollivier JP, Gandjbakhch I, Delettre E, Bussiere JL. XeCl excimer laser coronary angioplasty: a convergence of favourable factors. J Photochem Photobiol 1990: B 6:249–257.
79. Muller-Stolzenburg N, Muller GJ. Transmission of 308 nm excimer laser radiation for ophthalmic microsurgery—medical, technical and safety aspects. Biomed.Tech.(Berl) 1989:34:131–138.
80. Novak Z, Bonis B, Baltas E, Ocsovszki I, Ignacz F, Dobozy A, Kemeny L. Xenon chloride ultraviolet B laser is more effective in treating psoriasis and in inducing T cell apoptosis than narrow-band ultraviolet B. J Photochem Photobiol B. 2002;67:32–8.
81. Bonis B, Kemeny L, Dobozy A, Bor Z, Szabo G, Ignacz F. 308 nm UVB excimer laser for psoriasis [letter]. Lancet 1997; 350 (9090):1522.
82. Asawanonda P, Anderson RR, Chang Y, Taylor CR. 308-nm excimer laser for the treatment of psoriasis: a dose-response study. Arch Dermatol 2000; 136:619–624.
83. Kemeny L, Bonis B, Dobozy A, Bor Z, Szabo G, Ignacz F. 308-nm Excimer laser therapy for psoriasis. Arch Dermatol 2001; 137:95–96.
84. Housman TS, Pearce DJ, Feldman SR. Case Report: Efficacy of 308 nm excimer laser therapy for psoriasis. Cosmet Dermatol 2001:14:17–20.
85. Trehan M, Taylor CR. High-dose 308-nm excimer laser for the treatment of psoriasis. J Am Acad Dermatol. 2002;46:732–7.
86. Feldman SR, Mellen BG, Housman TS, Fitzpatrick RE, Geronemus RG, Friedman PM, Vasily DB, Morison WL. Efficacy of the 308-nm excimer laser for treatment of psoriasis: Results of a multicenter study. J Am Acad Dermatol. 2002 Jun;46:900–906.
87. Zelickson BD, Mehregan DA, Wendelschfer-Crabb G, Ruppman D, Cook A, O’Connell P, Kennedy WR. Clinical and histologic evaluation of psoriatic plaques treated with a flashlamp pulsed dye laser. J Am Acad Dermatol 1996: 35:64–68, 1996.
88. Hern S, Allen MH, Sousa AR, Harland CC, Barker JN, Levick JR, Mortimer PS. Immunohistochemical evaluation of psoriatic plaques following selective photothermolysis of the superficial capillaries. Br J Dermatol. 2001 Jul;145(1): 45–53.
89. Housman TS, Rohrback JM, Fleischer AB Jr, Feldman SR. Phototherapy utilization for psoriasis is declining in the United States. J Am Acad Dermatol 2002;46:557–9.
90. Fleischer AB Jr, Clark AR, Rapp SR, Reboussin DM, Feldman SR. Commercial tanning bed treatment is an effective psoriasis treatment: results from an uncontrolled clinical trial. J Invest Dermatol 1997;109:170–174.